Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;45(1):63-9.

Effect of Omega-3 Supplementation on Lipocalin 2 and Retinol-Binding Protein 4 in Type 2 Diabetic Patients

Affiliations

Effect of Omega-3 Supplementation on Lipocalin 2 and Retinol-Binding Protein 4 in Type 2 Diabetic Patients

Payam Farahbakhsh-Farsi et al. Iran J Public Health. 2016 Jan.

Abstract

Background: Serum levels of lipocalin 2 (LCN 2) and retinol-binding protein-4 (RBP 4), increase in type 2 diabetes mellitus (T2DM). We sought to determine whether serum LCN 2 and RBP 4 change after an intervention with omega-3 fatty acids supplementation in diabetic patients.

Methods: Forty-five type 2 diabetic patients from Iranian Diabetic Association in Tehran, Iran in 2013 were randomly recruited into two groups: one group received 4 g/d omega-3 for 10 wk; and the control group received placebo. Blood samples, food intake records, anthropometric measurements were obtained from all participants at the beginning and end of the study.

Results: Fasting RBP 4 plasma levels significantly changed after 10 wk supplementation (P = 0.01). The LCN 2 concentrations decreased in omega-3 group, but the changes were not statistically significant. Omega-3 supplementation had no noticeable effect on anthropometric factors.

Conclusions: These findings provide a rationale for omega-3 supplements aimed at lowering serum RBP 4 levels in T2DM.

Keywords: Diabetes mellitus; Lipocalin; Omega-3 fatty acid; Retinol-binding protein.

PubMed Disclaimer

Similar articles

References

    1. Kehrer JP. (2010). Lipocalin-2: pro- or anti-apoptotic? Cell Biol Toxicol, 26: 83–9. - PubMed
    1. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. (2005). Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. FASEB J, 19: 1881–3. - PubMed
    1. Stejskal D, Karpisek M, Humenanska V, Hanulova Z, Stejskal P, Kusnierova P, Petzel M. (2008). Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA. Horm Metab Res, 40: 381–5. - PubMed
    1. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED. (2007). The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes, 56: 2533–40. - PubMed
    1. Tan BK, Adya R, Shan X, Syed F, Lewandowski KC, O'Hare JP, Randeva HS. (2009). Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin. Diabetes Care, 32: 129–31. - PMC - PubMed

LinkOut - more resources